Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award
Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )
14 Jun 2015

Applications of chimaeric antigen receptor T-cells in leukaemia

Dr Carl June - University of Pennsylvania, Philadelphia, USA
Applications of chimaeric antigen receptor T-cells in leukaemia ( Dr Carl June - University of Pennsylvania, Philadelphia, USA )
14 Jun 2015

EHA 2015: Expert opinions on new treatment standard in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon
EHA 2015: Expert opinions on new treatment standard in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon )
13 Jun 2015

The latest in multiple myeloma: a European and US perspective

Prof Paul Richardson and Prof Marivi Mateos
The latest in multiple myeloma: a European and US perspective ( Prof Paul Richardson and Prof Marivi Mateos )
13 Jun 2015

Advances in the treatment and management of CLL

Prof Clemens Wendtner and Prof Peter Hillmen
Advances in the treatment and management of CLL ( Prof Clemens Wendtner and Prof Peter Hillmen )
13 Jun 2015

Transplantation combined with novel agents optimal treatment for multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA
Transplantation combined with novel agents optimal treatment for multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )
13 Jun 2015

Monoclonal antibodies and multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA
Monoclonal antibodies and multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )
13 Jun 2015

Factors influencing response to blinatumomab in relapsed/refractory ALL

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany
Factors influencing response to blinatumomab in relapsed/refractory ALL ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )
12 Jun 2015

Targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia

Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia
Targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia ( Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia )
12 Jun 2015

New targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia

Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia
New targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia ( Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia )
12 Jun 2015

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece
Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Jun 2015

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

Dr Emiliano Calvo - START Madrid, Madrid, Spain
PM1183 plus doxorubicin shows interesting activity in small cell lung cancer ( Dr Emiliano Calvo - START Madrid, Madrid, Spain )
12 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation